DSS, INC. (DSS)
$0.00+$0.00 (+0.00%) Latest sessionExtended Hours
DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 21,852 | $18K |
| Other acquisition / disposition | 2 | 16,554,055 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
5 Form 4 filings on record, the earliest from Dec 13, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Heng Fai Ambrose Chan - Director | Open-market sale | Common Stock | 21,852 | $0.82 | $18K | |
| Heng Fai Ambrose Chan - Director | Other | Convertible Promissory Note | 0 | $0.74 | - | |
| Heng Fai Ambrose Chan - Director | Other | Common Stock Purchase Warrant | 16,554,055 | $0.93 | $15.40M | |
| Heng Fai Ambrose Chan - Director | Open-market sale | Common Stock | 130,679 | $1.35 | $176K | |
| Heng Fai Ambrose Chan - Director | Other | Convertible Promissory Note | 0 | - | - | |
| Heng Fai Ambrose Chan - Director | Open-market purchase | Common Stock | 820,597 | $0.97 | $800K | |
| Heng Fai Ambrose Chan - Director | Open-market purchase | Common Stock | 205,149 | $0.97 | $200K |
DSS, INC. (DSS) had 2 insider filings in the last 90 days, with the most recent on 2026-09-08. The full record for DSS runs to 5 Form 4 filings, the earliest from 2024-12-13. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of DSS were filed in the last 90 days. 2 purchases are on record for this company.
1 insider sale of DSS was filed in the last 90 days, totaling $18K.
This page tracks DSS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add DSS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
